-
-
New study designs investigating impact of ONGENTYS® (opicapone) on non-motor symptoms presented for first time at the MDS Virtual Congress 2021
-
Posted in Industry News
-
25th Sep 2021
-
News from Bial at the MDS congress
-
-
New support group for families affected by brain injury
-
Posted in Industry News
-
14th Sep 2021
-
New special interest group launched to support families of people with brain injury
-
-
Apomorphine Sublingual Film for PD
-
Posted in Industry News
-
14th Sep 2021
-
News from BIAL
-
-
Nerve Tumours UK
-
Posted in Industry News
-
22nd Aug 2021
-
News of the Neurofibromatosis Association
-
-
Ratlas: A new rat brain atlas set to revolutionise neuroscience
-
Posted in Industry News,Resources
-
18th Aug 2021
-
New resource from the BNA to increase efficiency and help reduce animal numbers in Neuroscience research
-
-
The Mike Barnes Award for Innovation 2021
-
Posted in Industry News,Rehabilitation Articles
-
17th Aug 2021
-
Deadline for entries 30th September 2021
-
-
MHRA approves PONVORY® (ponesimod) for the Treatment of Adults with Relapsing Forms of Multiple Sclerosis (RMS)
-
Posted in Industry News
-
10th Aug 2021
-
News from The Janssen Pharmaceutical Companies of Johnson & Johnson
-
-
Istradefylline: CHMP issues negative opinion for in Europe
-
Posted in Industry News
-
23rd Jul 2021
-
News from Kyowa Kirin Co. Ltd
-
-
Bial and Medis partnership
-
Posted in Industry News
-
21st Jul 2021
-
Industry news from Bial and Medis
-
-
STARS recognises healthcare professionals working to reduce misdiagnosis and sudden cardiac death
-
Posted in Awards & Appointments,Industry News
-
15th Jul 2021
-
New report from STARS, the Syncope Trust and Reflex anoxic Seizures